Muutke küpsiste eelistusi

E-raamat: Microbiota and Dietary Mediators in Colon Cancer Prevention and Treatment

Edited by , Edited by , Edited by
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 17-Feb-2025
  • Kirjastus: Springer Nature Switzerland AG
  • Keel: eng
  • ISBN-13: 9789819602971
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 246,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Microbiota and Dietary Mediators in Colon Cancer Prevention and TreatmentSuurem pilt
  • Formaat: EPUB+DRM
  • Ilmumisaeg: 17-Feb-2025
  • Kirjastus: Springer Nature Switzerland AG
  • Keel: eng
  • ISBN-13: 9789819602971
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

The book discusses the role of gut microbiome composition in colorectal cancer progression, linking intestinal inflammation, tumorigenesis and anti-cancer immune responses. Chapters delve into various areas, including the mechanisms of action of probiotics and prebiotics (such as Lactobacillus and Bifidobacterium strains, and fructans and galactans, respectively), functional foods such as -carotene, -carotene, lutein, -cryptoxanthin, fucoxanthin, isothiocyanates, flavonoids, probiotics, fibre and omega-3. Lycopene, -cryptoxanthin, and fucoxanthin. Dietary phytochemicals such as polyphenols (curcumin, gingerol, ferulic acid (FA) and hydroxytyrosol); alkaloids (piperine, and protopine); terpenoids (artemisinin, and astaxanthin); iridoid glycoside (picroside II, and morroniside); and flavonoid (quercetin) on cancer, immune responses, and the gut microbiome. It examines the interaction and influence of prebiotics and probiotics in colorectal cancer treatment, their use in managing chemotherapy-related gastrointestinal problems, and their potential as adjuvants. The book also investigates how these gut microbes are associated with tumor progression and anti-cancer treatment efficacy. This knowledge can be used to develop biomarkers that predict immunotherapy effectiveness and improve treatment outcomes through modulation.





This book provides a comprehensive update on the latest research and clinical applications in the field, offering valuable insights into the complex interplay between probiotics, the gut microbiome, and colorectal cancer. It serves as an invaluable resource for healthcare professionals, researchers, and students seeking to understand this dynamic area of study.

1. Gut microbiota and its Importance in Health and Disease.- 2Recent Innovations in Probiotics and Prebiotics and Gut health.-
3. The Mechanistic Perspectives of Functional Foods - Probiotics and Prebiotics: A Focus on Colon Cancer and Human Health.-
4. Health Benefits of Probiotics and Prebiotics interaction.-
5. Genetically Engineered Probiotics and Potential in Therapeutic Applications.-
6. Probiotic, Prebiotic, and Gut-Brain Connection in Cancer Development.-
7. The influence of prebiotics and probiotics in colorectal cancer treatment.-
8. ROLE OF DIETARY PHYTOCHEMICALS IN GUT DYSBIOSIS: IMPLICATIONS IN COLON CANCER PREVENTION AND TREATMENT.-
9. Probiotics: Immune responses and gut microbiome.-
10. Probiotics Formulation and Cancer Nano-vaccines in GI-Tract Cancer.-
11. Association between Gut Microbiome and Liver and Colon Cancer.-
12. Prebiotic Fortification: Millets in Building Resilience Against Colon Cancer.-
13. Probiotics in Colorectal Cancer: An Emphasis on Immunomodulatory and Anti-Cancer Properties.-
14. Cancer Risk in Alterations of Prebiotics.-
15. Priming the Nutrition-Gut-Immuno-Oncology Axis.-
16. Probiotics & Prebiotics in IBS. Therapeutic role of probiotics & prebiotics in irritable bowel syndrome.

Prof. Surajit Pathak, Ph.D., is a leading researcher and academic, currently a Professor at Chettinad Academy of Research and Education in Chennai. With a Ph.D. from India (2007) and a post-doctoral journey at renowned institutions like the University of Alabama (USA), University of Padova (Italy), and University of Linkoping (Sweden), his research focuses on microRNAs for early colorectal cancer detection. Prof. Pathak has published various research articles, and he is a member of global research societies. His work continues to shape advancements in cancer research and stem cell biology globally.





Dr. Antara Banerjee, Ph.D., is currently working as an Associate Professor at Chettinad Academy of Research and Education (CARE), Chennai. Dr. Banerjee pursued her post-doctoral research on Cancer Biology and Regenerative Medicine at the University of Padova, Italy, and Linkoping University, Sweden. These works fostered her interest in understanding the role of the mesenchymal niche and extra-cellular vesicles in tissue regeneration and exploring signaling pathways in governing stem cell fate. Dr. Banerjee has edited several books on Stem Cells and Cancer. She is affiliated with professional research bodies and is a member of several international research societies.





Professor Asim K. Duttaroy is a leading expert in nutrition and medical science, renowned for his groundbreaking research in lipid metabolism, cardiovascular health, and chronic disease prevention. He has significantly contributed to understanding how food bioactive compounds impact human health. His pioneering work on the cardio-protective properties of fruits e.g., "the role of fruitflow (tomato extract) and kiwifruit extract in reducing platelet aggregation and blood pressure, has led to international patents. His innovative research continues to influence global health strategies and food-based therapies.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97898196029716e.html